Inflammatory neuropathies

Seminars in Neurology

Volumn 30, Issue 4, 2010, Pages 356-364

  Whitesell, Jackie ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

acute inflammatory demyelinating polyradiculoneuropathy; chronic inflammatory demyelinating polyradiculopathy; Guillain Barr syndrome; Lewis Sumner syndrome; multifocal motor neuropathy

Indexed keywords

BRAIN PROTEIN; CORTICOSTEROID; ENZYME ANTIBODY; GANGLIOSIDE GQ 1B ANTIBODY; GLUCURONOSYLTRANSFERASE 1A ANTIBODY; GLUCURONOSYLTRANSFERASE 1B ANTIBODY; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; UNCLASSIFIED DRUG;

ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; ACUTE MOTOR AXONAL NEUROPATHY; ACUTE SENSORY AXONAL NEUROPATHY; AREFLEXIA; ATAXIA; BICKERSTAFF BRAINSTEM ENCEPHALITIS; CANOMAD SYNDROME; CEREBROSPINAL FLUID; CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; DISEASE COURSE; DISEASE DURATION; DRUG MEGADOSE; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; ENCEPHALITIS; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY NEUROPATHY; LEWIS SUMNER SYNDROME; MOTOR NEUROPATHY; MULTIFOCAL MOTOR NEUROPATHY; NERVE BIOPSY; NERVE CONDUCTION; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOPLEGIA; PATHOGENESIS; PLASMAPHERESIS; POEMS SYNDROME; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; REVIEW; SENSORY NEUROPATHY;

DIAGNOSIS, DIFFERENTIAL; GUILLAIN-BARRE SYNDROME; HUMANS; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYRADICULONEUROPATHY; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 77958071482     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0030-1267279     Document Type: Review

References (64)

1. Hughes R A., Rees J H. Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis 1997 176 (Suppl 2) S92-S98
2. G. Guillain JBaAS. Sur un syndrome de radiculonevrite avec hyperalbuminose du liquide cephalo-rachidien sans reaction cellilaire. Remarques sur les caracteres cliniques et graphiques des reflexes tendineux. Bull Soc Med Hop Paris 1916 1462-1470
3. Ropper AHWE, Truax B Guillain-Barre Syndrome. Philadelphia, PA FA Davis Company 1991
4. Winer J B., Hughes R A., Anderson M J., Jones D M., Kangro H, Watkins R P. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 1988 51 (5) 613-618
5. Moulin D E., Hagen N, Feasby T E., Amireh R, Hahn A. Pain in Guillain-Barré syndrome. Neurology 1997 48 (2) 328-331
6. Hadden R D., Karch H, Hartung H P. et al, Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology 2001 56 (6) 758-765
7. Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain-Barré syndrome. Drug Saf 2009 32 (4) 309-323
8. Hafer-Macko C E., Sheikh K A., Li C Y. et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 1996 39 (5) 625-635
9. Albers J W., Kelly J J. Jr. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 1989 12 (6) 435-451
10. Van den Bergh P Y., Piéret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2004 29 (4) 565-574
11. Gordon P H., Wilbourn A J. Early electrodiagnostic findings in Guillain-Barré syndrome. Arch Neurol 2001 58 (6) 913-917
12. Albers J W., Donofrio P D., McGonagle T K. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1985 8 (6) 528-539
13. Miller R G., Peterson G W., Daube J R., Albers J W. Prognostic value of electrodiagnosis in Guillain-Barré syndrome. Muscle Nerve 1988 11 (7) 769-774
14. Gorson K C., Ropper A H., Muriello M A., Blair R. Prospective evaluation of MRI lumbosacral nerve root enhancement in acute Guillain-Barré syndrome. Neurology 1996 47 (3) 813-817
15. McKhann G M., Griffin J W., Cornblath D R., Mellits E D., Fisher R S., Quaskey S A. Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol 1988 23 (4) 347-353
16. Cornblath D R., Mellits E D., Griffin J W. et al. Motor conduction studies in Guillain-Barré syndrome: description and prognostic value. Ann Neurol 1988 23 (4) 354-359
17. Bernsen R A., de Jager A E., Schmitz P I., van der Meché F G. Long-term impact on work and private life after Guillain-Barré syndrome. J Neurol Sci 2002 201 (1-2) 13-17
18. Feasby T E., Gilbert J J., Brown W F. et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986 109 (Pt 6) 1115-1126
19. Griffin J W., Li C Y., Ho T W. et al. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol 1996 39 (1) 17-28
20. Hughes R A., Cornblath D R. Guillain-Barré syndrome. Lancet 2005 366 (9497) 1653-1666
21. Chaudhry V, Corse A M., Cornblath D R., Kuncl R W., Freimer M L., Griffin J W. Multifocal motor neuropathy: electrodiagnostic features. Muscle Nerve 1994 17 (2) 198-205
22. Ang C W., Jacobs B C., Laman J D. The Guillain-Barré syndrome: a true case of molecular mimicry. Trends Immunol 2004 25 (2) 61-66
23. Yuki N, Taki T, Takahashi M et al. Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope. Infect Immun 1994 62 (5) 2101-2103
24. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956 255 (2) 57-65
25. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller-Fisher syndrome. Neurology 2001 56 (8) 1104-1106
26. Ilyas A A., Cook S D., Mithen F A. et al. Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome. J Neuroimmunol 1998 82 (2) 160-167
27. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller-Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993 43 (10) 1911-1917
28. Liu J X., Willison H J., Pedrosa-Domellöf F. Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci 2009 50 (7) 3226-3232
29. Kornberg A J., Pestronk A, Blume G M., Lopate G, Yue J, Hahn A. Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher and related syndromes. Neurology 1996 47 (5) 1317-1320
30. Jamal G A., MacLeod W N. Electrophysiologic studies in Miller-Fisher syndrome. Neurology 1984 34 (5) 685-688
31. Katsuno M, Ando T, Hakusui S, Yanagi T, Sobue G. Motor conduction studies in Miller-Fisher syndrome with severe tetraparesis. Muscle Nerve 2002 25 (3) 378-382
32. Bickerstaff E R. Brain-stem encephalitis; further observations on a grave syndrome with benign prognosis. BMJ 1957 1 (5032) 1384-1387
33. Bickerstaff E R., Cloake P C. Mesencephalitis and rhombencephalitis. BMJ 1951 2 (4723) 77-81
34. Mondéjar R R., Santos J M., Villalba E F. MRI findings in a remitting-relapsing case of Bickerstaff encephalitis. Neuroradiology 2002 44 (5) 411-414
35. Yuki N. Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome). J Neuroimmunol 2009 215 (1-2) 1-9
36. Austin J H. Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone. Brain 1958 81 (2) 157-192
37. Dyck P J., Lais A C., Ohta M, Bastron J A., Okazaki H, Groover R V. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 1975 50 (11) 621-637
38. Gorson K. Chronic inflammatory demyelinating polyradiculoneuropathy In: Daube JR, Dillingham TR, Bromberg MB, Werner RA Proceedings of the 56th Annual AANEM. San Diego, CA American Association of Neuromuscular & Electrodiagnostic Medicine 2009 1-13
39. Koski C L., Baumgarten M, Magder L S. et al. Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 2009 277 (1-2) 1-8
40. Dionne A, Nicolle M W., Hahn A F. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy. Muscle Nerve 2010 41 (2) 202-217
41. Benatar M Neuromuscular Disease: Evidence and Analysis in Clinical Neurology. Totowa, NJ Humana Press 2006
42. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991 41 617-618
43. Bladé J. Clinical practice. Monoclonal gammopathy of undetermined significance. N Engl J Med 2006 355 (26) 2765-2770
44. Yan W X., Taylor J, Andrias-Kauba S, Pollard J D. Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients. Ann Neurol 2000 47 (6) 765-775
45. Meléndez-Vásquez C, Redford J, Choudhary P P. et al. Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 1997 73 (1-2) 124-134
46. Gorson K C., Allam G, Ropper A H. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 1997 48 (2) 321-328
47. Kuwabara S, Misawa S, Mori M, Tamura N, Kubota M, Hattori T. Long-term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases. J Neurol Neurosurg Psychiatry 2006 77 (1) 66-70
48. Parry G J., Clarke S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve 1988 11 (2) 103-107
49. Pestronk A, Cornblath D R., Ilyas A A. et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988 24 (1) 73-78
50. Slee M, Selvan A, Donaghy M. Multifocal motor neuropathy: the diagnostic spectrum and response to treatment. Neurology 2007 69 (17) 1680-1687
51. Bouche P, Moulonguet A, Younes-Chennoufi A B. et al. Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry 1995 59 (1) 38-44
52. Nobile-Orazio E, Cappellari A, Priori A. Multifocal motor neuropathy: current concepts and controversies. Muscle Nerve 2005 31 (6) 663-680
53. Van Asseldonk J T., Franssen H, Van den Berg-Vos R M., Wokke J H., Van den Berg L H. Multifocal motor neuropathy. Lancet Neurol 2005 4 (5) 309-319
54. Lambrecq V, Krim E, Rouanet-Larrivière M, Lagueny A. Sensory loss in multifocal motor neuropathy: a clinical and electrophysiological study. Muscle Nerve 2009 39 (2) 131-136
55. Pestronk A, Choksi R. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates. Neurology 1997 49 (5) 1289-1292
56. Beekman R, van den Berg L H., Franssen H, Visser L H., van Asseldonk J T., Wokke J H. Ultrasonography shows extensive nerve enlargements in multifocal motor neuropathy. Neurology 2005 65 (2) 305-307
57. Nobile-Orazio E. Multifocal motor neuropathy. J Neuroimmunol 2001 115 (1-2) 4-18
58. Van den Berg-Vos R M., Franssen H, Wokke J H., Van Es H W., Van den Berg L H. Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment. Ann Neurol 2000 48 (6) 919-926
59. Vucic S, Black K R., Chong P S., Cros D. Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg. Neurology 2004 63 (7) 1264-1269
60. Terenghi F, Cappellari A, Bersano A, Carpo M, Barbieri S, Nobile-Orazio E. How long is IVIg effective in multifocal motor neuropathy? Neurology 2004 62 (4) 666-668
61. Lewis R A., Sumner A J., Brown M J., Asbury A K. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982 32 (9) 958-964
62. Saperstein D S., Amato A A., Wolfe G I. et al. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve 1999 22 (5) 560-566
63. Viala K, Renié L, Maisonobe T et al. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain 2004 127 (Pt 9) 2010-2017
64. Lewis R A. Multifocal dysimmune demyelination neuropathies In: AANEM 2009 Courses A&B, ed. San Diego, CA American Association of Neuromuscular & Electrodiagnostic Medicine 2009 35-43